Clinical Trial Update: A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of Xeomin injections to prevent episodic migraine and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Episodic Migraine

Drugs mentioned

• XEOMIN (INCOBOTULINUMTOXINA)

Snippet

Sponsor: Merz Therapeutics GmbH | Conditions: Episodic Migraine | Phase 3 | Status: RECRUITING